ContextLogic Inc. (LOGC)
NASDAQ: LOGC · Real-Time Price · USD
6.95
-0.15 (-2.11%)
At close: Mar 28, 2025, 4:00 PM
7.02
+0.07 (0.96%)
After-hours: Mar 28, 2025, 7:55 PM EDT
ContextLogic Revenue
In the year 2024, ContextLogic had annual revenue of $43.00M, down -85.02%.
Revenue (ttm)
$43.00M
Revenue Growth
-85.02%
P/S Ratio
4.15
Revenue / Employee
$5,375,000
Employees
8
Market Cap
182.88M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionLOGC News
- 16 days ago - ContextLogic Inc. (WISH) Q4 2024 Earnings Conference Call Transcript - Seeking Alpha
- 16 days ago - ContextLogic Inc. Reports Fourth-Quarter and Fiscal Year 2024 Financial Results - GlobeNewsWire
- 19 days ago - ContextLogic to Announce Fourth Quarter and Full Year 2024 Results and Provide Strategic Update on March 12, 2025 - GlobeNewsWire
- 5 months ago - ContextLogic Inc. Reports Third-Quarter 2024 Financial Results - GlobeNewsWire
- 8 months ago - ContextLogic Inc. Reports Second-Quarter Financial Results - GlobeNewsWire
- 2 years ago - Alexion, AstraZeneca Rare Disease, Completes Acquisition of LogicBio® Therapeutics - Business Wire
- 2 years ago - LogicBio Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates - PRNewsWire
- 2 years ago - LOGICBIO® THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of LogicBio® Therapeutics, Inc. - LOGC - Business Wire